French international pioneer in respiratory health.

Based in Nice, this excellence center aims to develop innovative approaches for diagnosing, treating and preventing respiratory diseases.

Our Upcoming Events

Portrait of Dr. Maria Teresa Landi.
Events
Lung cancer in never-smokers: a conference with Maria Teresa Landi
12/01/2026
RespirERA welcomes Maria Teresa Landi on 1 December for a conference on Sherlock-Lung and lung cancer in people who have never smoked.
Events
6th Joint Meeting on Lung Cancer in Nice on October 14–15, 2027
10/14/2027
- 10/15/2027
On October 14 and 15, 2027, in Nice, RespirERA will bring together international experts to discuss therapeutic innovations and predictive biomarkers in lung cancer.

Our News

Participants réunis à Nice pour le deuxième atelier IMPULSION.
Featured
Simplifying the IMPULSION lung cancer screening pathway
In Nice, the RespirERA Institute brought together patients and professionals to make it easier for IMPULSION participants to enrol, access their results and keep track of follow-up scans.
Visual for the 8th edition of Lung Cancer a New Vision, featuring the event title and an illustration of lungs.
Congress
Lung cancer: Professor Paul Hofman takes part in Lung Cancer a New Vision 2026
As a scientific committee member at Lung Cancer a New Vision 2026, Professor Paul Hofman contributed to discussions on treatment approaches and pathology and surgery reports.
Professor Paul Hofman receives the Research Award at ISLB 2026 in Madrid.
Congress
Liquid Biopsy: Professor Paul Hofman honoured at ISLB 2026 in Madrid
In Madrid, Professor Paul Hofman attended ISLB 2026 and received the Research Award in recognition of his contributions to liquid biopsy research.

Our Strategic Priorities

IHU RespirERA structures its actions around four complementary strategic priorities. Together, they aim to improve the understanding and prevention of respiratory diseases, enhance their diagnosis, personalize patient care, and widely disseminate research-driven innovations for the benefit of patients and society.

Our Missions

IHU RespirERA is committed to five key missions to explore the impact of aging and the environment on respiratory health, placing the patient at the heart of its projects.
Understand

the mechanisms of respiratory diseases to better address them.

Prevent

by identifying environmental risk factors and developing effective prevention strategies.

Treat

by creating personalized treatments tailored to each patient’s specific needs.

Innovate

by integrating new technologies, including artificial intelligence and robotics, to enhance diagnosis and care.

Educate & Train

healthcare professionals and the general public on emerging technologies and best practices.

Our Strategy

IHU RespirERA is built on a synergy between researchers, clinicians, patient associations, and industry partners, fostering effective collaboration to understand and treat respiratory diseases. This holistic approach considers all aspects of these pathologies, from biological factors to environmental impacts, to develop comprehensive and innovative solutions. The Provence-Alpes-Côte d’Azur region, significantly affected by pollution and an aging population, serves as our "living laboratory", enabling us to develop real-world solutions tailored to environmental and health challenges.

Our Projects

Discover our flagship projects that need your support!

Liquid biopsy: a blood test to diagnose lung cancer
Toward more precise and less invasive diagnosis of lung cancer for better targeted treatments
Innovative biomarkers: tissue, liquid and AI
Towards earlier diagnosis and targeted treatments thanks to innovative biomarkers, liquid biopsy and AI.
Dépistage du cancer du poumon
IHU RespirERA is a leading actor in the deployment of lung cancer screening in France.

Support Us

to give new life to research!

By supporting IHU RespirERA, you are directly contributing to the funding of our innovative projects across all areas of respiratory health.

Every donation is a breath of fresh air for research.

Our Founding Members

Our Institutional Support

Supported by the ANR through France 2030: ANR-23-IAHU-0007